Redwood Investment Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,139
Closed -$201K 301
2022
Q1
$201K Buy
+4,139
New +$214K 0.03% 272

Other funds holding ASTH

Redwood Investment Management's ASTH Position: Q2 2022 in Review

Redwood Investment Management sold out of Astrana Health (ASTH) in Q2 2022, closing a stake of 4,139 shares — an estimated $201K sold.

Redwood Investment Management first reported a position in ASTH in Q1 2022 and held it in 1 quarter. The position peaked at $201K in Q1 2022. 134 funds tracked by Wall St. Rank hold ASTH as of Q2 2022.

  • Redwood Investment Management reported no remaining Astrana Health position as of Q2 2022 after selling out during the quarter.
  • Redwood Investment Management sold 4,139 Astrana Health shares in Q2 2022, an estimated $201K.
  • Redwood Investment Management first reported a position in Astrana Health in Q1 2022 and held it in 1 quarter.
  • Redwood Investment Management's Astrana Health position peaked at $201K in Q1 2022.
  • 134 funds tracked by Wall St. Rank held Astrana Health as of Q2 2022.

Based on Redwood Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.